SOFIA Study |
2011-05-24 |
CIGB |
CENTAURO Study |
2011-04-29 |
CIGB |
Dermosep-I |
2010-12-20 |
CIGB |
EPANEM-III |
2010-12-20 |
CIGB |
CIGB-247 vaccine in patients with solid malignant tumors, phase I, randomized. (CENTAURO-2 study) |
2013-06-06 |
CIGB |
BACONAO Study |
12/11/2021 |
CIGB |
VISION Study |
26/10/2021 |
CIGB |
CIGB-500 in acute myocardial infarction (AMIGOS study) |
23/04/2014 |
CIGB |
CIGB-247-V vaccine in Age-Related Macular Degeneration, phase I-II randomized. |
10/11/2014 |
CIGB |
Safety and pharmacokinetics of CIGB-552 |
22/05/2015 |
CIGB |
Expanded Clinical Use of Nasalferon in COVID-19 |
10/11/2021 |
CIGB |
COURAGE Study |
27/05/2016 |
CIGB |
HEBERFERON in renal cell carcinoma |
05/01/2017 |
CIGB |
CENTAURO-4 Study |
30/04/2017 |
CIGB |
ESAR-814 Study |
26/01/2017 |
CIGB |
CENTAURO-6 Study |
16/02/2017 |
CIGB |
Transfer factor in Chronic Kidney Disease |
06/08/2020 |
CIGB |
HEBERBIOVAC HB vaccine to reference material. |
30/04/2017 |
CIGB |
HeberNasvac® Phase IV in Chronic Hepatitis B |
03/08/2018 |
CIGB |
EGF in bilateral symmetric diabetic neuropathy |
23/03/2020 |
CIGB |